Drug – bio-affecting and body treating compositions – Conjugate or complex of monoclonal or polyclonal antibody,... – Conjugated via claimed linking group – bond – chelating agent,...
Patent
1977-02-25
1978-06-20
Brown, Johnnie R.
Drug, bio-affecting and body treating compositions
Conjugate or complex of monoclonal or polyclonal antibody,...
Conjugated via claimed linking group, bond, chelating agent,...
260430, 536118, 536121, 536122, 536117, A61K 3170, C07H 1104, C07H 1312
Patent
active
040962504
ABSTRACT:
The compounds are tri-substituted phosphinegold(I) 1-thio-.beta.-D-glucopyranosides which have antiarthritic activity and, in particular, are of use in the treatment of rheumatoid arthritis. Of the three substituents on the phosphine one is optionally substituted phenyl and the others are lower alkyl or lower alkoxy.
REFERENCES:
patent: 3635945 (1972-01-01), Nemeth et al.
Brown Johnnie R.
Edgerton William H.
Foggio Richard D.
Keps Joan S.
SmithKline Corporation
LandOfFree
Tri-substituted phosphinegold(I) 1-thio-.beta.-D-glucopyranoside does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tri-substituted phosphinegold(I) 1-thio-.beta.-D-glucopyranoside, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tri-substituted phosphinegold(I) 1-thio-.beta.-D-glucopyranoside will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1134720